Biology:SEQ-400

From HandWiki

SEQ-400 is a vaccine against urinary tract infections (UTIs) which is under development for potential medical use.[1][2][3] It is a vaccine against the Escherichia coli FimH adhesin protein, which is essential for bacterial infection.[3] The vaccine is being developed by Sequoia Sciences.[1][2] As of September 2023, it is in phase 2 clinical trials.[1][2] SEQ-400 is being developed for potential approval and use in the United States.[1]

See also

References

  1. ↑ 1.0 1.1 1.2 1.3 "SEQ 400". 15 September 2023. https://adisinsight.springer.com/drugs/800045995. 
  2. ↑ 2.0 2.1 2.2 "Delving into the Latest Updates on SEQ-400 with Synapse". 23 January 2025. https://synapse.patsnap.com/drug/3e0eb2e0e0b14c47981f9248197a50ad. 
  3. ↑ 3.0 3.1 "Why Do Urinary Tract Infections (UTI) Recur?". 3 May 2024. https://asm.org/articles/2024/may/why-urinary-tract-infections-uti-recur. 



Retrieved from "https://handwiki.org/wiki/index.php?title=Biology:SEQ-400&oldid=4079426"